Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
becatecarin dna topoisomerase i NA Successful target TTD , DGIDB Malignant neoplasm of stomach[MeSHID:D013274]
leukemia[MeSHID:D007938]
Neoplasms[MeSHID:D009369]
Malignant neoplasm of liver[MeSHID:D008113]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 0.22 discontinued in phase 3 inhibitor
becatecarin dna topoisomerase 2-alpha small molecule NA drugbank , DGIDB Malignant neoplasm of stomach[MeSHID:D013274]
leukemia[MeSHID:D007938]
Neoplasms[MeSHID:D009369]
Malignant neoplasm of liver[MeSHID:D008113]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 0.53 investigational unknown
becatecarin dna topoisomerase 2-alpha small molecule NA drugbank , DGIDB Malignant neoplasm of stomach[MeSHID:D013274]
leukemia[MeSHID:D007938]
Neoplasms[MeSHID:D009369]
Malignant neoplasm of liver[MeSHID:D008113]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 0.53 investigational inhibitor
becatecarin dna topoisomerase 2-beta small molecule NA drugbank , DGIDB Malignant neoplasm of stomach[MeSHID:D013274]
leukemia[MeSHID:D007938]
Neoplasms[MeSHID:D009369]
Malignant neoplasm of liver[MeSHID:D008113]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 1.01 investigational inhibitor
becatecarin dna topoisomerase 2-beta small molecule NA drugbank , DGIDB Malignant neoplasm of stomach[MeSHID:D013274]
leukemia[MeSHID:D007938]
Neoplasms[MeSHID:D009369]
Malignant neoplasm of liver[MeSHID:D008113]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 1.01 investigational unknown
click here to return to the previous page